Back
Allianz SE Vs. Keros Therapeutics Industry Stock Comparison
Buy
83
ALIZY
Allianz SE
Last Price:
32.93
Seasonality Move:
10.27%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Buy
83
Allianz SE (ALIZY)
is a Buy
Is Allianz SE a Buy, Sell or Hold?
- The current Allianz SE [ALIZY] share price is $33.08. The Score for ALIZY is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- ALIZY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALIZY Stock Price Chart
What is Allianz SE's stock price today?
-
The Allianz SE share price today is $33.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIZY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
ALIZY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.83 | Buy |
Relative Strength Index (14 RSI): | 77.25 | Buy |
Chaikin Money Flow: | 60995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.78 - 32.36) | Buy |
Bollinger Bands (100): | (27.58 - 30.72) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.17 | Buy |
Relative Strength Index (14 RSI): | 64.2 | Buy |
Chaikin Money Flow: | -162874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.46 - 56.8) | Buy |
Bollinger Bands (100): | (45.02 - 53.82) | Buy |
ALIZY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.57 | Buy |
20-day SMA: | 31.79 | Buy |
50-day SMA: | 29.93 | Buy |
200-day SMA: | 28.34 | Buy |
8-day EMA: | 32.57 | Buy |
20-day EMA: | 31.81 | Buy |
50-day EMA: | 30.53 | Buy |
200-day EMA: | 28.27 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.92 | Buy |
20-day SMA: | 53.86 | Buy |
50-day SMA: | 50.03 | Buy |
200-day SMA: | 52.7 | Buy |
8-day EMA: | 55.87 | Buy |
20-day EMA: | 53.93 | Buy |
50-day EMA: | 51.33 | Buy |
200-day EMA: | 49.85 | Buy |
Allianz SE Earnings Growth & ALIZY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.30 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Allianz SE Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |